- Case Report
- Open Access
Multiple infarcts and hemorrhages in the central nervous system of a dog with cerebral amyloid angiopathy: a case report
BMC Veterinary Research volume 14, Article number: 370 (2018)
β-amyloid (Aβ) can accumulate in the brain of aged dogs, and within vessels walls, the disease is called cerebral amyloid angiopathy (CAA). In humans, Alzheimer’s disease and CAA are strongly correlated with cerebrovascular disease. However, in dogs, this association has not been extensively studied yet. The present report highlights the pathological and clinical features of a concomitant cerebrovascular disease and amyloid precursor protein (APP) accumulation in the brain of a dog.
A female, 16-year-old, Standard Poodle with a one-year history of cognitive deficits presented with an acute onset of right-sided postural reaction deficit and circling, left-sided head tilt, positional nystagmus, and ataxia. Due to poor prognosis the dog was euthanized, and pathological examination of the brain revealed an acute lacunar infarction within the thalamus extending to rostral colliculus. Additional findings included subacute and chronic areas of ischemia throughout the brain and areas of hemorrhage within the medulla. Immunolabeling revealed APP deposition within intraparenchymal vessels of frontal, temporal and occipital cortex, hippocampus, diencephalon, mesencephalon and myelencephalon, besides meningeal vessels walls. Glial fibrillary acidic protein (GFAP) immunolabeling showed marked astrocytosis around the acute area of infarction and within chronic areas of ischemia. Histological examination of the brain along with immunohistochemistry results showed a concomitant APP, which is an Aβ precursor, accumulation within the neuroparenchyma and vessels (CAA) with histological evidences of a cerebrovascular disease in an aged dog.
This report shows that APP accumulation in the brain can occur concomitantly to a severe cerebrovascular disease in a dog. Further studies are necessary to elucidate if cerebrovascular disease is associated with Aβ accumulation in the brain of dogs.
Cerebrovascular disease (CVD), defined as any abnormality of the central nervous system (CNS) resulted from pathologic processes that compromises the blood supply , is a well-recognized cause of disability in humans. Despite its relative rarity, CVD is now recognized as a cause of neurological disfunction in dogs and cats and can be either classified as ischemic or hemorrhagic [2, 3]. Vessel occlusion by thromboembolism resulting in ischemic stroke and vessel rupture causing hemorrhage are the main direct consequences of CVD in dogs and cats . Chronic hypertension, which results in atherosclerosis and lipohyalinosis in small penetrating arteries of the brain, is also suspected of being one of the main underlying conditions that may predispose dogs to CVD [4, 5]. Other predisposing conditions may include neoplasia, sepsis, hypothyroidism, parasites, vascular malformation, and coagulopathy .
Cerebral amyloid angiopathy (CAA), which is characterized by the deposition of β-amyloid peptide (Aβ) in parenchymal and leptomeningeal blood vessels, is a common disease in aged people, and associated with Alzheimer’s disease (AD) . In dogs, a condition like AD, characterized by accumulation of senile plaques composed either by Aβ or Aβ precursor protein (APP), has been well described [7,8,9,10,11,12]. Importantly, the accumulation of Aβ within blood vessels (CAA), has also been reported in dogs [7, 10, 11]. In humans, CAA has been associated with vascular lesions, such as ischemic infarcts and intracerebral hemorrhages . Intracerebral hemorrhages have also been reported in association with CAA in dogs .
Although infarcts, hemorrhages and white matter loss have been associated with CAA in humans , few studies have reported the occurrence of both brain infarcts and hemorrhages in dogs with CAA. The aim of the present study was to describe the clinical and pathological aspects of infarctions and hemorrhages within the CNS of a dog with APP deposition within vascular walls.
A female, 16-year-old, Standard Poodle was presented at a private veterinary clinic. The owner reported several changes in the mental status 1 year prior to clinical examination. These changes were recognized as confusion and reduced awareness, impaired recognition of human family members and loss of previously learned abilities. Two days prior to clinical examination, the animal presented with a generalized tonic-clonic seizure. Subsequently, the animal presented with a poor appetite and lethargy, with circling and ataxia.
The neurologic exam revealed acute right-sided abnormalities characterized by postural reaction deficit, circling, and head and neck turn in addition to left-sided head tilt, positional nystagmus, and ataxia. The owner declined to perform a magnetic resonance imaging exam.
The clinical signs evolved to lateral recumbency and the dog was unable to feed itself, characterizing a poor prognosis. Therefore, the dog was euthanized and submitted for necropsy at the Department of Pathology of the School of Veterinary Medicine and Animal Science (FMVZ), University of São Paulo (USP). The brain was entirely fixed in 10% buffered formalin and routinely processed for histology. Sections of the brain were stained with hematoxylin and eosin, and were also submitted for immunohistochemistry for detection of APP and glial fibrillary acidic protein (GFAP). Briefly, several sections of CNS were submitted to antigen retrieval with citrate buffer pH 6.0. Then, the slides were incubated with primary antibodies anti-APP (Millipore, Darmstadt, Germany) and anti-GFAP (Dako, Agilent, Santa Clara, California, USA) diluted at 1:200 and 1:14000, respectively. The antigen-antibody binding was visualized using EnVision FLEX System kit (Dako, Agilent, Santa Clara, California, USA), according to manufacturer’s instructions. As a positive control for APP staining, a brain of dog with traumatic brain injury with axonal degeneration was used. A brain of a young dog without significant histological lesions were used as negative control for APP labeling.
Grossly, the lateral ventricles were mildly distended, with flattened gyri and mild widening of sulci.
Histologically, intraparenchymal and leptomeningeal blood vessels from many areas of CNS, including the myelencephalon up to cerebral cortex were mildly to severely thickened by an acellular and hyaline material. On the right paramedian region, extending from the thalamus, at the level of diencephalon and mesencephalon junction to the oculomotor nucleus, at the level of rostral colliculus, there was a locally extensive, well demarcated, lacunar area with marked loss of neuroparenchyma tinctorial properties with coagulative necrosis surrounded by a rim of severe spongiosis (Fig. 1a). Within the area of necrosis, multifocally, neurons had a pyknotic nuclei and hypereosinophilic cytoplasm (neuronal necrosis). There was also necrosis and degeneration of glial and endothelial cells, characterized by pyknotic and karyorrhectic nuclei (Fig. 1b). The perivascular compartments of surrounding vessels were infiltrated by a low number of histiocytes (Fig. 1c). Within the area of spongiosis there was a large number of swollen axons forming axonal spheroids (axonal degeneration). GFAP immunolabeling showed an increase in the number, complexity, and thickness of astrocytic process (astrogliosis) surrounding the necrotic lesion (Fig. 1d). Within the necrotic area, the astrocytic processes were not evident. GFAP was mildly detected within degenerated and necrotic astrocytes inside the necrotic area. These findings are compatible with an acute area of ischemia/infarction with initial reactive gliosis with minimal inflammation.
Multifocally, lacunar areas of subacute infarction were visualized within the cerebellum, mainly involving the granular layer and adjacent white matter (Fig. 2a). The areas were characterized by a high number of granular cells with pyknotic and karyorrhectic nuclei, with liquefaction of neuropil, admixed with a moderate number of foam macrophages (Gitter cells) and axonal spheroids (Fig. 2b). These areas were surrounded by a moderate number of new-formed blood vessels with hypertrophied endothelial cells (neovascularization) with adjacent areas of hemorrhage and mild perivascular cuffing containing histiocytes. Prominent astrogliosis, demonstrated with GFAP immunolabeling, involving also the Bergman glia were visualized at the periphery of these necrotic areas (Fig. 2c).
Chronic lacunar areas of ischemia were also present within the telencephalon at the level of basal nuclei and hippocampus. These areas were pallor, well demarcated with neuron loss and with a marked proliferation of capillaries with hypertrophied endothelial cells. There was a mild to moderate spongiosis with an increase in the number of glial cells (gliosis), including a moderate number of cells with an abundant eosinophilic cytoplasm and an eccentric nuclei (gemistocytes). Rare perivascular cuffing of small number of histiocytes were visualized. Within these areas there was a marked increase in the number of astrocytes (astrocytosis) and astrogliosis as demonstrated by GFAP immunolabeling (Fig. 2d).
In additional to the areas of ischemia/infarcts, within the medulla at the level of obex, there were multifocal areas of hemorrhage within the reticular formation and several nuclei (Fig. 3). The white matter of many areas, including telencephalon to the myelencephalon, were variably degenerated.
APP immunolabeling were visualized more frequently within the wall of intraparenchymal blood vessels (Fig. 4a), and occasionally affecting leptomeningeal vessels. Intensity of APP immunolabeling varied from mild to severe, according to Attems . APP affected vessels from many areas of the CNS, but had a patchy distribution, characterized by APP-positive areas with adjacent APP-negative areas. Frontal lobes and temporal lobes were more affected when compared to occipital lobes. Other affected areas included the hippocampus, diencephalon, mesencephalon and myelencephalon. The cerebellum was less affected. Rarely, vessels with dyschoric change were observed, which consists in additional spreading of APP from vessels to adjacent neuropil (Fig. 4b). Importantly, a large number of hyalinized vessels weren’t immunolabeled for APP, especially those with a higher wall thickness. Within the periphery of the acute infarction, swollen and degenerating axons were immunolabeled for APP (Fig. 4c).
At the level of rostral commissure (basal nuclei) and thalamus there are locally extensive areas where a multifocal staining for APP was visualized within the neuroparenchyma. Within these areas, two types of APP staining were seen. Small, up to 25 μm in diameter, areas of staining containing a round, dense and darkly stained central region (Fig. 4d) were visualized in addition to other labeled areas, in which a central darkly stained core was not present (Fig. 4e) .
The brain of a young dog used as negative control didn’t exhibit APP immunostaining within CNS vessels or within the neuroparenchyma (Fig. 4f).
Discussion and conclusions
The diagnosis of CAA was based on histological changes observed in blood vessels, and by demonstration of APP by immunohistochemistry within the wall of these vessels. In dogs, similarly as in humans, Aβ is derived from APP . Therefore, in the present study, the detection of APP highly suggests an ongoing cerebrovascular disease associated with Aβ deposition. Besides vascular walls, APP immunolabeling was also visualized within the neuroparenchyma in some areas of the CNS in the dog from the present study. Importantly, this dog had histological lesions related to vascular injury, such as areas of ischemia/infarctions and hemorrhages.
Several neurological changes, like those observed in humans have been described in the CNS of old dogs (reviewed by Vite and Head ). These pathological changes, among others, includes Aβ deposits, CAA, vascular disease, and infarcts . The post-mortem examination of 16-year-old dog from the present study that presented with acute neurological signs prior to death, revealed that this dog had a severe CAA, in addition to intraparenchymal Aβ deposits, which are found in AD. In humans, these disorders are correlated with each other, and the prevalence of CAA in AD is over 70% . The severity of CAA has been correlated with progressing AD pathology . In dogs, a condition like AD in humans, with deposition of Aβ plaques has been described [7,8,9,10,11,12]. Similarly, Aβ deposition within the wall of intraparenchymal and meningeal vessels, resulting in CAA was reported in dogs [7, 10, 11].
In addition to CAA and Aβ deposits in the brain, the dog from the present report had several areas of ischemia/infarction and hemorrhages in the brain. In humans, CAA has been associated with these vascular disorders . In CAA, elastic elements and smooth muscle are replaced by Aβ deposition, which could induce aneurysms and consequently intracerebral hemorrhages . In dogs, intracerebral hemorrhage has been associated with CAA .
In the present study, the cerebral ischemic infarcts had a lacunar distribution, demonstrating that intraparenchymal, small and penetrating arteries were the most likely affected vessels. In a previous study, the cause of lacunar infarcts in dogs couldn’t be determined . Ischemic cerebral infarcts have been observed in patients with CAA, which could be a risk factor for cerebral infarcts in aged people . Although the exactly pathogenic mechanism of occurrence of ischemic infarcts associated with CAA is not known , Aβ could induce loss of vascular reactivity resulting in a more severe ischemia, with reduction of collateral circulation in ischemic tissues at risk for infarction . In the present case, thickened and hyalinized, intraparenchymal and meningeal vessels that were not immunolabeled for APP were visualized in the dog from the present report. Histologically, these vessels resemble those found in aged people with vascular dementia . Although CAA could contribute for development of ischemic injury in the present case, we cannot rule out other vascular pathological processes. There is an increase evidence of overlapping of AD and cerebrovascular lesions . Vascular changes in the aged brains can be found in a significant proportion of AD patients . Cerebrovascular lesions and AD may coexist in earlier stages of cognitive impairment and may influence its severity and progression, thus making its diagnosis challenging even for neuropathologists .
The dog from the present report had cognitive deficits for 1 year such as impaired recognition of human family members and loss of previously learned abilities. Multiple subacute and chronic areas of ischemia in the brain of this dog, as evidenced by astrocytic reactivity within these areas, demonstrates that this dog was suffering from an ongoing cerebrovascular disease. The cognitive deficits presented by this dog are most likely due to Aβ deposition in the brain and neuronal loss due to the multiple old areas of ischemia . However, the dog presented acute neurological signs, and at neurological exam had an ipsilateral postural reaction deficit, ipsilateral circling, and head and neck turn with contralateral head tilt, positional nystagmus, and ataxia. These signs are probably due to the acute ischemic infarct histologically visualized extending from the thalamus to the diencephalon and mesencephalon junction. Similar clinical signs were observed in dogs with midbrain/thalamic infarcts .
In conclusion, this report shows a concomitant neurodegenerative disease characterized by APP deposition, which is an Aβ precursor, within the neuroparenchyma and vessels with a severe cerebrovascular disease in an aged dog. Further studies are necessary to elucidate the relationship between vascular disease and Aβ accumulation in the brain of dogs.
amyloid precursor protein
cerebral amyloid angiopathy
central nervous system
Department of Pathology of the School of Veterinary Medicine and Animal Science
glial fibrillary acidic protein
University of São Paulo
Kalimo H, Kaste M, Haltia M. Vascular diseases. In: Graham DI, Lantos PL, editors. Greenfield’s neuropathology. 7th ed. London: Arnold; 2002. p. 233–80.
Garosi LS. Cerebrovascular disease in dogs and cats. Vet Clin North Am Small Anim Pract. 2010;40(1):65–79.
Boudreau CE. An update on cerebrovascular disease in dogs and cats. Vet Clin North Am Small Anim Pract. 2018;48(1):45–62.
Wessmann A, Chandler K, Garosi L. Ischaemic and haemorrhagic stroke in the dog. Vet J. 2009;180(3):290–303.
Garosi L, McConnell JE, Platt SR, Barone G, Baron JC, de Lahunta A, et al. Results of diagnostic investigations and long-term outcome of 33 dogs with brain infarction (2000-2004). J Vet Intern Med. 2005;19(5):725–31.
Attems J. Sporadic cerebral amyloid angiopathy: pathology, clinical implications, and possible pathomechanisms. Acta Neuropathol. 2005;110(4):345–59.
Yoshino T, Uchida K, Tateyama S, Yamaguchi R, Nakayama H, Goto N. A retrospective study of canine senile plaques and cerebral amyloid angiopathy. Vet Pathol. 1996;33(2):230–4.
Cummings BJ, Head E, Ruehl W, Milgram NW, Cotman CW. The canine as an animal model of human aging and dementia. Neurobiol Aging. 1996;17(2):259–68.
Okuda R, Uchida K, Tateyama S, Yamaguchi R, Nakayama H, Goto N. The distribution of amyloid beta precursor protein in canine brain. Acta Neuropathol. 1994;87(2):161–7.
Uchida K, Miyauchi Y, Nakayama H, Goto N. Amyloid angiopathy with cerebral hemorrhage and senile plaque in aged dogs. Nihon Juigaku Zasshi. 1990;52(3):605–11.
Uchida K, Tani Y, Uetsuka K, Nakayama H, Goto N. Immunohistochemical studies on canine cerebral amyloid angiopathy and senile plaques. J Vet Med Sci. 1992;54(4):659–67.
Yu CH, Song GS, Yhee JY, Kim JH, Im KS, Nho WG, et al. Histopathological and immunohistochemical comparison of the brain of human patients with Alzheimer's disease and the brain of aged dogs with cognitive dysfunction. J Comp Pathol. 2011;145(1):45–58.
Garcia-Marin V, Blazquez-Llorca L, Rodriguez JR, Boluda S, Muntane G, Ferrer I, et al. Diminished perisomatic GABAergic terminals on cortical neurons adjacent to amyloid plaques. Front Neuroanat. 2009;3:28.
Cummings BJ, Su JH, Cotman CW, White R, Russell MJ. Beta-amyloid accumulation in aged canine brain: a model of early plaque formation in Alzheimer's disease. Neurobiol Aging. 1993;14(6):547–60.
Vite CH, Head E. Aging in the canine and feline brain. Vet Clin North Am Small Anim Pract. 2014;44(6):1113–29.
Attems J, Jellinger KA, Lintner F. Alzheimer's disease pathology influences severity and topographical distribution of cerebral amyloid angiopathy. Acta Neuropathol. 2005;110(3):222–31.
Garosi L, McConnell JF, Platt SR, Barone G, Baron JC, de Lahunta A, et al. Clinical and topographic magnetic resonance characteristics of suspected brain infarction in 40 dogs. J Vet Intern Med. 2006;20(2):311–21.
Cadavid D, Mena H, Koeller K, Frommelt RA. Cerebral beta amyloid angiopathy is a risk factor for cerebral ischemic infarction. A case control study in human brain biopsies. J Neuropathol Exp Neurol. 2000;59(9):768–73.
Zhang F, Eckman C, Younkin S, Hsiao KK, Iadecola C. Increased susceptibility to ischemic brain damage in transgenic mice overexpressing the amyloid precursor protein. J Neurosci. 1997;17(20):7655–61.
Roman G, Kalaria R. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging. 2006;27(12):1769–85.
Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer's disease--lessons from pathology. BMC Med. 2014;12:206.
Availability of data and materials
All data generated from this study are included in the published article, including patient data.
Ethics approval and consent to participate
The patient owner’s provided written, informed consent for the clinical assessment, euthanasia and necropsy of their dog.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.